MENU
+Compare
VERA
Stock ticker: NASDAQ
AS OF
Sep 12 closing price
Price
$23.77
Change
-$0.76 (-3.10%)
Capitalization
1.52B

VERA Vera Therapeutics Forecast, Technical & Fundamental Analysis

Vera Therapeutics Inc is a clinical stage biotechnology company... Show more

VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VERA with price predictions
Sep 12, 2025

Aroon Indicator for VERA shows an upward move is likely

VERA's Aroon Indicator triggered a bullish signal on September 12, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 191 similar instances where the Aroon Indicator showed a similar pattern. In of the 191 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VERA's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 05, 2025. You may want to consider a long position or call options on VERA as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VERA just turned positive on August 13, 2025. Looking at past instances where VERA's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

VERA moved above its 50-day moving average on September 05, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for VERA crossed bullishly above the 50-day moving average on September 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VERA advanced for three days, in of 258 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VERA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VERA broke above its upper Bollinger Band on September 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.239) is normal, around the industry mean (20.524). P/E Ratio (0.000) is within average values for comparable stocks, (53.276). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.172). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (337.274).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. VERA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VERA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VERA is expected to report earnings to fall 5.00% to -113 cents per share on November 05

Vera Therapeutics VERA Stock Earnings Reports
Q3'25
Est.
$-1.14
Q2'25
Missed
by $0.38
Q1'25
Missed
by $0.08
Q4'24
Beat
by $0.09
Q3'24
Missed
by $0.21
The last earnings report on August 05 showed earnings per share of -120 cents, missing the estimate of -81 cents. With 1.08M shares outstanding, the current market capitalization sits at 1.52B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
8000 Marina Boulevard
Phone
+1 650 770-0077
Employees
51
Web
https://www.veratx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MECIX56.38N/A
N/A
AMG GW&K International Small Cap I
PLSAX31.93N/A
N/A
Principal Large Cap S&P 500 Index A
FSDPX95.18N/A
N/A
Fidelity Select Materials
JACRX14.31N/A
N/A
Easterly Global Real Estate C
TFIFX48.82N/A
N/A
T. Rowe Price Financial Services I

VERA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with KYMR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
-3.10%
KYMR - VERA
59%
Loosely correlated
+1.71%
LYRA - VERA
54%
Loosely correlated
-0.63%
CRNX - VERA
40%
Loosely correlated
+0.80%
NRIX - VERA
38%
Loosely correlated
-1.74%
NUVL - VERA
38%
Loosely correlated
-2.13%
More